Pat is a highly successful entrepreneur in the Pharmaceutical Services sector. As CEO, Pat has built and led three companies to successful exits including Advarra, (leading North American IRB), Aptiv Solutions (global clinical development services company), and PRA International (leading global full-service CRO).
Mr. Shea joined Rediscovery Life Sciences as CEO in 2019. He is an experienced life sciences entrepreneur and has been involved in the creation and growth of multiple life science start-ups over the last 20 years. Mr. Shea also serves as CEO of Basking Biosciences. Mr. Shea was CEO of Vascular Pharmaceuticals from 2010-2017 and advanced its development candidate through the completion of Phase 2 in diabetic kidney disease.
Rick is Dean of the University of Arizona College of Pharmacy and a founder of RLS. He is a leading pharmacologist, researcher, and drug discovery entrepreneur. Rick joined UA in August 2016 from the Medical University of South Carolina (MUSC). At MUSC, Rick chaired the college’s Department of Drug Discovery and Biomedical Sciences from 2001 to 2015, and his research led to the discovery of the renal protective effects of suramin.
Anita has worked in diverse sectors in both the private and non-profit arenas for more than two decades. As the Director for Rex Health Ventures, she leads a team for the venture arm of UNC Health, the largest academic health system serving the state of North Carolina. Rex Health Ventures’ mission is to spur innovation in healthcare through equity investments and partnerships with emerging health care early-stage companies.
Sunil is President of Orlando Health Medical Group. He leads a network of more than 1,000 employed clinicians and also practices part-time in the intensive care unit of Orlando Health Orlando Regional Medical Center (ORMC). An accomplished executive and physician, Sunil is board certified in internal medicine, pulmonary medicine, critical care medicine, and sleep medicine. Before joining Orlando Health, Sunil served as president of Christus St. Vincent Medical Group in Santa Fe, New Mexico.
Dave is a founding member of Solas BioVentures. He currently focuses on investments in medical device and therapeutic companies. Dave is board certified in Maternal-Fetal Medicine, Obstetrics and Gynecology, and Hypertension, with special expertise in Critical Care. Dave recently retired from a 30-year clinical and teaching career and has 20 years of experience in angel and venture investing in life sciences.